|
1
|
Kamangar F, Dores GM and Andeson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
Cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watanabe R, Ishiura N, Nakashima H, Kuwano
Y, Okochi H, Tamaki K, Sato S, Tedder TF and Fujimoto M: Regulatory
B cells (B10 cells) have a suppressive role in murine lupus: CD19
and B10 cell deficiency exacerbates systemic autoimmunity. J
Immunol. 184:4801–4809. 2010. View Article : Google Scholar
|
|
5
|
Olkhanud PB, Damdinsuren B, Bodogai M,
Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP and Biragyn A:
Tumor-evoked regulatory B cells promote breast cancer metastasis by
converting resting CD4+ T cells to T-regulatory cells.
Cancer Res. 71:3505–3515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schioppa T, Moore R, Thompson RG, Rosser
EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM and Balkwill FR: B
regulatory cells and the tumor promoting actions of TNF-α during
squamous carcinogenesis. Proc Natl Acad Sci USA. 108:10662–10667.
2011.PubMed/NCBI
|
|
7
|
Huang C and Fu ZX: Localization of
IL-17+Foxp3+ T cells in esophageal cancer.
Immunol Invest. 40:400–412. 2011.
|
|
8
|
Mauri C and Bosma A: Immune regulatory
function of B cells. Annu Rev Immunol. 30:221–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lund FE and Randall TD: Effector and
regulatory B cells: modulators of CD4+ T cell immunity.
Nat Rev Immunol. 10:236–247. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noh G and Lee JH: Regulatory B cells and
allergic diseases. Allergy Asthma Immunol Res. 3:168–177. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watanabe R, Fujimoto M, Ishiura N, Kuwano
Y, Nakashima H, Yazawa N, Okochi H, Sato S, Tedder TF and Tamaki K:
CD19 expression in B cells is important for suppression of contact
hypersensitivity. Am J Pathol. 171:560–570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanaba K, Bouaziz JD, Haas KM, Poe JC,
Fujimoto M and Tedder TF: A regulatory B cell subset with a unique
CD1dhiCD5+ phenotype controls T cell-dependent
inflammatory responses. Immunity. 28:639–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsushita T, Yanaba K, Bouaziz JD,
Fujimoto M and Tedder TF: Regulatory B cells inhibit EAE initiation
in mice while other B cells promote disease progression. J Clin
Invest. 118:3420–3430. 2008.PubMed/NCBI
|
|
14
|
Fillatreau S, Sweenie CH, McGeachy MJ,
Gray D and Anderton SM: B cells regulate autoimmunity by provision
of IL-10. Nat Immunol. 3:944–950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizoguchi A, Mizoguchi E, Takedatsu H,
Blumberg RS and Bhan AK: Chronic intestinal inflammatory condition
generates IL-10-producing regulatory B cell subset characterized by
CD1d upregulation. Immunity. 16:219–230. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fillatreau S, Gray D and Anderton SM: Not
always the bad guys: B cells as regulators of autoimmune pathology.
Nat Rev Immunol. 8:391–397. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
DiLillo DJ, Matsushita T and Tedder TF:
B10 cells and regulatory B cells balance immune responses during
inflammation, autoimmunity, and cancer. Ann NY Acad Sci.
1183:38–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mauri C and Ehrenstein MR: The ‘short’
history of regulatory B cells. Trends Immunol. 29:34–40. 2008.
|
|
19
|
Mizoguchi A and Bhan AK: A case for
regulatory B cells. J Immunol. 176:705–710. 2006. View Article : Google Scholar
|
|
20
|
Mosser D and Zhang X: Interleukin-10: new
perspectives on an old cytokine. Immunol Rev. 226:205–218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. Seventh
edition. Springer; New York, NY: 2010
|
|
22
|
Inoue S, Leitner WW, Golding B and Scott
D: Inhibitory effects of B cells on antitumor immunity. Cancer Res.
66:7741–7747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen T, Song D, Min Z, et al:
Perioperative dynamic alterations in peripheral regulatory T and B
cells in patients with hepatocellular carcinoma. J Transl Med.
10:142012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Im SH, Hueber A, Monticelli S, Kang KH and
Rao A: Chromatin-level regulation of the IL10 gene in T cells. J
Biol Chem. 279:46818–46825. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JH, Noh J, Noh G, Choi WS and Lee SS:
IL-10 is predominantly produced by the CD19(low)CD5(+) regulatory B
cell subpopulation: characterization of CD19(high) and CD19(low)
subpopulations of CD5(+) B cells. Yonsei Med J. 52:851–855. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee JH, Noh J, Noh G, Kim HS, Mun SH, Choi
WS, Cho S and Lee S: Allergen-specific B cell subset responses in
cow’s milk allergy of late eczematous reactions in atopic
dermatitis. Cell Immunol. 262:44–51. 2010.
|
|
27
|
Itoh S and Itoh F: Implication of TGF-β as
a survival factor during tumour development. J Biochem.
151:559–562. 2012.
|
|
28
|
Hoshino Y, Katsuno Y, Ehata S and Miyazono
K: Autocrine TGF-β protects breast cancer cells from apoptosis
through reduction of BH3-only protein, Bim. J Biochem. 149:55–65.
2011.
|
|
29
|
Edlund S, Bu S, Schuster N, Aspenström P,
Heuchel R, Heldin NE, ten Dijke P, Heldin CH and Landström M:
Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of
prostate cancer cells involves Smad7-dependent activation of p38 by
TGF-beta-activated kinase 1 and mitogen-activated protein kinase
kinase 3. Mol Biol Cell. 14:529–544. 2003. View Article : Google Scholar
|
|
30
|
Miller AV, Alvarez SE, Spiegel S and
Lebman DA: Sphingosine kinases and sphingosine-1-phosphate are
critical for transforming growth factor beta-induced extracellular
signal-regulated kinase 1 and 2 activation and promotion of
migration and invasion of esophageal cancer cells. Mol Cell Biol.
28:4142–4151. 2008. View Article : Google Scholar
|
|
31
|
Tian J, Zekzer D, Hanssen L, Lu Y, Olcott
A and Kaufman DL: Lipopolysaccharide-activated B cells
down-regulate Th1 immunity and prevent autoimmune diabetes in
nonobese diabetic mice. J Immunol. 167:1081–1089. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee JH, Noh J, Noh G, Choi WS, Cho S and
Lee SS: Allergen-specific transforming growth factor-β-producing
CD19+CD5+ regulatory B-cell (Br3) responses
in human late eczematous allergic reactions to cow’s milk. J
Interferon Cytokine Res. 31:441–449. 2011.
|
|
33
|
Hori S, Nomura T and Sakaguchi S: Control
of regulatory T cell development by the transcription factor Foxp3.
Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang G, Liu G, Liu Y, Li X and Su Z: FOXP3
Expression in esophageal cancer cells is associated with poor
prognosis in esophageal cancer. Hepatogastroenterology.
59:2186–2191. 2012.PubMed/NCBI
|
|
35
|
Noh J, Choi WS, Noh G and Lee JH: Presence
of Foxp3-expressing CD19(+)CD5(+) B Cells in human peripheral blood
mononuclear cells: Human CD19(+)CD5(+)Foxp3(+) regulatory B cell
(Breg). Immune Netw. 10:247–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baumgartner C, Osl M, Netzer M and
Baumgartner D: Bioinformatic-driven search for metabolic biomarkers
in disease. J Clin Bioinforma. 1:22011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X and Liotta L: Clinical
bioinformatics: a new emerging science. J Clin Bioinforma. 1:12011.
View Article : Google Scholar : PubMed/NCBI
|
